NCT04422821View on ClinicalTrials.gov

Flash Glucose Monitoring in Gestational Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

October 31, 2022

Study Completion Date

November 10, 2022

Conditions
Gestational Diabetes Mellitus
Interventions
DEVICE

Flash Glucose Monitoring

Flash Glucose Monitoring FreeStyle Libre™ (Abbott Diabetes Care, Alameda, CA) sensor placed subcutaneously that will be applied for 14 days, then removed and changed for the second sensor for the next 14 days.

DEVICE

Self-Monitoring of Blood Glucose

Self-Monitoring of Blood Glucose with a standard glucose meter (iXell®; Genexo sp; Warsaw, Poland) performed through a skin-puncturing 4 times a day for 28 days.

Trial Locations (1)

02-015

1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Warsaw

All Listed Sponsors
lead

Medical University of Warsaw

OTHER

NCT04422821 - Flash Glucose Monitoring in Gestational Diabetes Mellitus: Study Protocol for a Randomized Controlled Trial | Biotech Hunter | Biotech Hunter